Zdravka Medarova

Zdravka Medarova

Company: TransCode Therapeutics

Job title: CTO


Novel siRNA-Based Therapies for Cancer 2:00 pm

Development and proof-of-concept studies validating the potential of siRNA for tumor targeting Application of a novel RNAi-based checkpoint inhibitor for the treatment of pancreatic cancer Potential of RNAi-based cancer therapy: A longer-term look at the future of RNAi for the treatment of cancerRead more

day: Track B Day 1 AM

Panel Discussion – From Theory to Reality: Targeting Cancer with siRNA Therapeutics 2:15 pm

In the past year, siRNA therapeutics have rocketed as a widely promising potential therapy for several diseases. With the major shift of interest in oncology, it is critical to now consider the viability of targeting the tumors for therapeutic intervention & debate the important next steps to ensure siRNA cancer drugs become a reality Addressing…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.